The marketing of osteoporosis

American Journal of Nursing

Volumn 109, Issue 4, 2009, Pages 58-61

  Napoli, Maryann ^a  

^a Center for Medical Consumers   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

ADVERTIZING; DRUG INDUSTRY; DRUG UTILIZATION; EVIDENCE BASED PRACTICE; FINANCIAL MANAGEMENT; HUMAN; MASS MEDIUM; MASS SCREENING; METHODOLOGY; NURSE ATTITUDE; OSTEOPOROSIS; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT SELECTION; PHOTON ABSORPTIOMETRY; PREDICTION AND FORECASTING; PSYCHOLOGICAL ASPECT; REVIEW; RISK ASSESSMENT; RISK REDUCTION; STATISTICS;

ABSORPTIOMETRY, PHOTON; ADVERTISING AS TOPIC; ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; DRUG INDUSTRY; DRUG UTILIZATION; EVIDENCE-BASED PRACTICE; HUMANS; MARKETING OF HEALTH SERVICES; MASS MEDIA; MASS SCREENING; NURSE'S ROLE; OSTEOPOROSIS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK REDUCTION BEHAVIOR;

EID: 64049109163     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.NAJ.0000348606.24360.7d     Document Type: Article

References (22)

1. Cheung AM, Detsky AS. Osteoporosis and fractures: missing the bridge? JAMA 2008;299(12):1468-70.
2. Kazanjian A, et al. Normal bone mass, aging bodies, marketing of fear: bone mineral density screening of well women. Vancouver, BC: British Columbia Office of Health Technology Assessment, Centre for Health Services and Policy Research, University of British Columbia; 1998 Sep. http://www.chspr.ubc. ca/files/publications/1998/bco98-10C.pdf.
3. National Osteoporosis Foundation. Fast facts on osteoporosis. 2008. http://www.nof.org/osteoporosis/diseasefacts.htm.
4. Kozak LJ, et al. National Hospital Discharge Survey: 2004 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13 2006(162):1-209.
5. Moynihan R, Cassels A. Selling sickness: how the world's biggest pharmaceutical companies are turning us all into patients. New York: Nation Books; 2005.
6. Davis RJ. The healthy skeptic: cutting through the hype about your health. Berkeley, CA: University of California Press; 2008.
7. Petersen M. Our daily meds: how the pharmaceutical companies transformed themselves into slick marketing machines and hooked the nation on prescription drugs. New York: Farrar, Straus and Giroux; 2008.
8. Mintzes B. For and against: direct to consumer advertising is medicalising normal human experience: for. BMJ 2002; 324(7342):908-9.
9. Thomson PDR. Physicians' desk reference: PDR. Montvale, NJ: Thomson Healthcare; 2005.
10. Center for Drug Evaluation and Research. FDA alert: information on bisphosphonates (marketed as Actonel, Actonel+Ca, Aredia, Boniva, Didronel, Fosamax, Fosamax+D, Reclast, Skelid, and Zometa). Rockville, MD: U.S. Food and Drug Administration; 2008 Nov 12. http://www.fda.gov/cder/ drug/infopage/bisphosphonates/default.htm.
11. Kwek EB, et al. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury 2008;39(2):224-31.
12. Lenart BA, et al. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 2008;358(12):1304-6.
13. Neviaser AS, et al. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 2008;22(5):346-50.
14. Sedghizadeh P P, et al. Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry. J Am Dent Assoc 2009;140(1):61-6.
15. Love SM, Lindsey K. Dr. Susan Love's hormone book: making informed choices about menopause. 1st ed. New York City: Random House; 1997.
16. Napoli M. Fosamax, a new drug with an ad campaign that encourages misuse. HealthFacts 1996;21(206):4.
17. Agency for Healthcare Research and Quality. U.S. Preventive Services Task Force. Screening for osteoporosis in postmenopausal women. Rockville, MD; 2002 Sep. http://www. ahrq.gov/clinic/uspstf/uspsoste.htm.
18. Abramson J, Wright JM. Are lipid-lowering guidelines evidence-based? Lancet 2007;369(9557):168-9.
19. Carey J. Do cholesterol drugs do any good? BusinessWeek 2008 Jan 17. http://www.businessweek.com/magazine/ content/08-04/b4068052092994.htm.
20. Center for Science in the Public Interest. Cholesterol recommendations questioned. CSPI, doctors want independent review of research on statins [press release]. CSPI Newsroom 2004 Sep 23. http://www.cspinet.org/integrity/ press/ 200409231.html.
21. Lenzer J. Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign. BMJ 2002;324(7339):723-9.
22. National Heart Lung and Blood Institute. ATP III update 2004: financial disclosure. Third report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Institutes of Health. 2004. http://www.nhlbi.nih.gov/ guidelines/cholesterol/atp3upd04-disclose.htm.